Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth M Gaughan

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
American Journal of Ophthalmology Case Reports|March 4, 2022
Multiple evanescent white dot syndrome-like reaction associated with ipilimumab and nivolumab immune checkpoint inhibitor therapy for metastasis of choroidal melanomaRyan T Duong, Naveen R Ambati, Krishi V Peddada, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|March 19, 2026
MHC Class I and PD-L1 Expression May Predict Treatment Response to Anti-PD-1/PD-L1 Therapy in Metastatic Triple-negative Breast Cancer PatientsJoseph L Maniaci, Hijun Ryu, Anne M Mills, et al.
Journal for Immunotherapy of Cancer|December 30, 2016
Sarcoidosis in the setting of combination ipilimumab and nivolumab immunotherapy: a case report & review of the literatureJoshua E Reuss, Paul R Kunk, Anne M Stowman, et al.
BMC Urology|September 2, 2009
HIV-associated bladder cancer: a case series evaluating difficulties in diagnosis and managementElizabeth M Gaughan, Bruce J Dezube, Mark Bower, et al.
Cardio-Oncology (London, England)|September 28, 2020
Severe combined cardiac and neuromuscular toxicity from immune checkpoint blockade: an institutional case seriesPuja Arora, Laura Talamo, Patrick Dillon, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|February 22, 2023
PD-L1 and MHC Class I Expression in High-grade Ovarian Cancers, Including Platinum-resistant Recurrences Treated With Checkpoint Inhibitor TherapyLaurie Griesinger, Akua Nyarko-Odoom, Santos Acosta Martinez, et al.
Journal of Thoracic Disease|January 21, 2012
Case series of treatment approaches in fit nonagenarians with stage IV non-small-cell lung cancerGregory J Britt, Elizabeth M Gaughan, Kim-Son H Nguyen, et al.
Annals of Surgery|July 7, 2022
Multicenter Experience with Neoadjuvant Therapy in Melanoma Highlights Heterogeneity in Contemporary PracticeKristen E Rhodin, Elizabeth M Gaughan, Vignesh Raman, et al.
Cancers|June 28, 2023
Relevance of the Updated Recursive Partitioning Analysis (U-RPA) Classification in the Contemporary Care of Patients with Brain MetastasesCamilo E Fadul, Guneet Sarai, Joseph A Bovi, et al.
Journal for Immunotherapy of Cancer|June 29, 2019
A multipeptide vaccine plus toll-like receptor agonists LPS or polyICLC in combination with incomplete Freund's adjuvant in melanoma patientsMarit M Melssen, Gina R Petroni, Kimberly A Chianese-Bullock, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
American Journal of Ophthalmology Case Reports|March 4, 2022
Multiple evanescent white dot syndrome-like reaction associated with ipilimumab and nivolumab immune checkpoint inhibitor therapy for metastasis of choroidal melanomaRyan T Duong, Naveen R Ambati, Krishi V Peddada, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|March 19, 2026
MHC Class I and PD-L1 Expression May Predict Treatment Response to Anti-PD-1/PD-L1 Therapy in Metastatic Triple-negative Breast Cancer PatientsJoseph L Maniaci, Hijun Ryu, Anne M Mills, et al.
Journal for Immunotherapy of Cancer|December 30, 2016
Sarcoidosis in the setting of combination ipilimumab and nivolumab immunotherapy: a case report & review of the literatureJoshua E Reuss, Paul R Kunk, Anne M Stowman, et al.
BMC Urology|September 2, 2009
HIV-associated bladder cancer: a case series evaluating difficulties in diagnosis and managementElizabeth M Gaughan, Bruce J Dezube, Mark Bower, et al.
Cardio-Oncology (London, England)|September 28, 2020
Severe combined cardiac and neuromuscular toxicity from immune checkpoint blockade: an institutional case seriesPuja Arora, Laura Talamo, Patrick Dillon, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|February 22, 2023
PD-L1 and MHC Class I Expression in High-grade Ovarian Cancers, Including Platinum-resistant Recurrences Treated With Checkpoint Inhibitor TherapyLaurie Griesinger, Akua Nyarko-Odoom, Santos Acosta Martinez, et al.
Journal of Thoracic Disease|January 21, 2012
Case series of treatment approaches in fit nonagenarians with stage IV non-small-cell lung cancerGregory J Britt, Elizabeth M Gaughan, Kim-Son H Nguyen, et al.
Annals of Surgery|July 7, 2022
Multicenter Experience with Neoadjuvant Therapy in Melanoma Highlights Heterogeneity in Contemporary PracticeKristen E Rhodin, Elizabeth M Gaughan, Vignesh Raman, et al.
Cancers|June 28, 2023
Relevance of the Updated Recursive Partitioning Analysis (U-RPA) Classification in the Contemporary Care of Patients with Brain MetastasesCamilo E Fadul, Guneet Sarai, Joseph A Bovi, et al.
Journal for Immunotherapy of Cancer|June 29, 2019
A multipeptide vaccine plus toll-like receptor agonists LPS or polyICLC in combination with incomplete Freund's adjuvant in melanoma patientsMarit M Melssen, Gina R Petroni, Kimberly A Chianese-Bullock, et al.
Pageof 3